Managers

CAMP4 Therapeutics lands $30 mln Series A

Cambridge, Massachusetts-based CAMP4 Therapeutics, has raised $30 million in Series A funding. The investors included Polaris Partners, the Kraft Group and Andreessen Horowitz.

Ancora Heart attracts $17.8 mln

Santa Clara, California-based Ancora Heart Inc, a developer of treatments for heart failure, has raised $17.8 million in funding. The round is expected to reach $30 million. Savitr Capital was among the investors.

TVC Capital targets $180 mln for fourth venture fund

TVC Capital is targeting $180 million for a fourth venture fund, according to a regulatory filing.

Amaranthine Partners targets $50 mln for venture fund

Amaranthine Partners is targeting $50 million for a maiden venture fund, according to a regulatory filing.

Venture’s emerging data gap

Moderne Ventures collects $42.7 mln for inaugural fund

Moderne Ventures has raised $42.7 million for its maiden fund, according to an SEC listing. No target was listed on the document. Chicago-based Moderne Ventures invests in early-stage tech companies in the real estate, finance, insurance and home services industries.

German seed-stage investor HTGF wraps up third fund

German seed-stage investor High-Tech Gründerfonds has closed its third fund at 316.5 million euros, beating its target of 310 million euros. The fund's investors include Germany's Federal Ministry for Economic Affairs and Energy and the KfW. HTGF III invests in in tech startups.

AbSci fetches $12 mln Series C

Vancouver, Washington-based AbSci, a provider of biomanufacturing technologies, has closed $12 million in Series C financing. Asahi Glass Co. Ltd led the round with participation from Phoenix Venture Partners, Oregon Venture Fund, WRF Capital, Souther Co., Columbia Ventures Corporation and GreenBridge. In conjunction with the funding, Dr. Gustavo Mahler, president and CEO of AGC Biologics, will join AbSci's board of directors.

Digital therapeutics company Propeller Health rakes in $20 mln

Madison, Wisconsin-based Propeller Health, a digital therapeutics company, has raised $20 million in funding. Aptar Pharma led the round with participation from return backers Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One.

CleanSlate inks $25 mln in HealthQuest-led round

CleanSlate, a provider of outpatient addiction medicine, has secured $25 million in financing. HealthQuest Capital led the round.